{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:15:32Z","timestamp":1778818532168,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203357"],"award-info":[{"award-number":["82203357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["22YF1442800"],"award-info":[{"award-number":["22YF1442800"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cllc.2026.03.015","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:53:04Z","timestamp":1775231584000},"page":"160-169.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant Therapy After Pathologic Complete Response to Neoadjuvant Immunochemotherapy in Non\u2013Small Cell Lung Cancer: A Multicenter Retrospective Real-World Study"],"prefix":"10.1016","volume":"27","author":[{"given":"Haoran","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhitao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanpu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cllc.2026.03.015_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.cllc.2026.03.015_bib0002","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.annonc.2025.08.003","article-title":"Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Zer","year":"2025","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2026.03.015_bib0003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cac2.12505","article-title":"Management of locally advanced non-small cell lung cancer: state of the art and future directions","volume":"44","author":"Miao","year":"2024","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10.1016\/j.cllc.2026.03.015_bib0004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"9","key":"10.1016\/j.cllc.2026.03.015_bib0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.6004\/jnccn.2025.0043","article-title":"NCCN Guidelines(R) insights: non-small cell lung cancer, version 7.2025","volume":"23","author":"Riely","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.cllc.2026.03.015_bib0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamaoncol.2023.5276","article-title":"Rapid advances in resectable non-small cell lung cancer: a narrative review","volume":"10","author":"West","year":"2024","journal-title":"JAMA Oncol"},{"issue":"9928","key":"10.1016\/j.cllc.2026.03.015_bib0007","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(13)62159-5","article-title":"Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data","volume":"383","author":"Group","year":"2014","journal-title":"Lancet"},{"issue":"10459","key":"10.1016\/j.cllc.2026.03.015_bib0008","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(24)01756-2","article-title":"Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Spicer","year":"2024","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.cllc.2026.03.015_bib0009","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.cllc.2026.03.015_bib0010","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cllc.2026.03.015_bib0011","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer","volume":"393","author":"Forde","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cllc.2026.03.015_bib0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the Neotorch randomized clinical trial","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cllc.2026.03.015_bib0013","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2213-2600(24)00269-8","article-title":"Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial","volume":"13","author":"Yue","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.cllc.2026.03.015_bib0014","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41591-023-02660-6","article-title":"Association between pathologic response and survival after neoadjuvant therapy in lung cancer","volume":"30","author":"Deutsch","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.cllc.2026.03.015_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.1285","article-title":"Neoadjuvant-adjuvant vs neoadjuvant-only PD-1 and PD-L1 inhibitors for patients with resectable NSCLC: an indirect meta-analysis","volume":"7","author":"Zhou","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.cllc.2026.03.015_bib0016","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jtho.2024.03.021","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for revision of the classification of residual tumor after resection for the forthcoming (Ninth) edition of the TNM classification of Lung Cancer","volume":"19","author":"Detterbeck","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.cllc.2026.03.015_bib0017","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.cllc.2026.03.015_bib0019","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jtcvs.2024.11.028","article-title":"Adjuvant immunotherapy does not improve survival in non-small cell lung cancer with major\/complete pathologic response after induction immunotherapy","volume":"169","author":"Zhao","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.cllc.2026.03.015_bib0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jtho.2024.09.1443","article-title":"Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis","volume":"20","author":"Marinelli","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.cllc.2026.03.015_bib0021","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.21037\/jtd-2024-2200","article-title":"Prognosis and relapse patterns in patients with non-small cell lung cancer with pathologic complete response after neoadjuvant immunochemotherapy","volume":"17","author":"Fang","year":"2025","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.cllc.2026.03.015_bib0022","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jtcvs.2025.04.028","article-title":"Lung cancer recurrence after neoadjuvant immunotherapy","volume":"170","author":"Li","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.cllc.2026.03.015_bib0023","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.cllc.2026.03.015_bib0024","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41591-025-03579-w","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial","volume":"31","author":"Tie","year":"2025","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.cllc.2026.03.015_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.annonc.2023.11.008","article-title":"Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer","volume":"35","author":"Tran","year":"2024","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.cllc.2026.03.015_bib0026","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jtho.2025.05.021","article-title":"Quantitative and dynamic ctDNA as a biomarker of response and survival in patients with advanced lung squamous cell carcinoma receiving immunochemotherapy or chemotherapy alone","volume":"20","author":"Zhou","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.cllc.2026.03.015_bib0027","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O'Brien","year":"2022","journal-title":"Lancet Oncol"},{"issue":"10308","key":"10.1016\/j.cllc.2026.03.015_bib0028","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cllc.2026.03.015_bib0029","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.chest.2024.06.3797","article-title":"Role of pathologic single-nodal and multiple-nodal descriptors in resected non-small cell lung cancer","volume":"166","author":"Takamori","year":"2024","journal-title":"CHEST"},{"issue":"8","key":"10.1016\/j.cllc.2026.03.015_bib0030","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jtho.2024.04.002","article-title":"Validation study for the N descriptor of the newly proposed ninth edition of the TNM staging system proposed by the International Association for the Study of Lung Cancer","volume":"19","author":"Kim","year":"2024","journal-title":"J Thorac Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730426000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730426000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:51:03Z","timestamp":1778817063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730426000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525730426000495"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2026.03.015","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Therapy After Pathologic Complete Response to Neoadjuvant Immunochemotherapy in Non\u2013Small Cell Lung Cancer: A Multicenter Retrospective Real-World Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2026.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}